Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohort

Kelly M Sunderland¹, Derek Beaton¹, Stephen R Arnott¹, Peter Kleinstiver², Donna Kwan³, Jane M Lawrence-Dewar⁴, Joel Ramirez⁵, Brian Tan¹, Robert Bartha^{6

7}, Sandra E Black^{5

8}, Michael Borrie^{2

9}, Donald Brien³, Leanne K Casaubon^{8

10}, Brian C Coe³, Benjamin Cornish¹¹, Allison A Dilliott^{2

6}, Dar Dowlatshahi^{12

13}, Elizabeth Finger^{2

14}, Corinne Fischer¹⁵, Andrew Frank^{12

16}, Julia Fraser¹¹, Morris Freedman^{1

8

17}, Barry Greenberg¹⁸, David A Grimes^{12

13}, Ayman Hassan⁴, Wendy Hatch^{19

20}, Robert A Hegele^{2

6}, Christopher Hudson^{20

21}, Mandar Jog²², Sanjeev Kumar^{23

24}, Anthony Lang²⁵, Brian Levine^{1

8

26}, Wendy Lou²⁷, Jennifer Mandzia^{2

28}, Connie Marras²⁵, William McIlroy¹¹, Manuel Montero-Odasso^{2

14

29}, David G Munoz¹⁵, Douglas P Munoz³, Joseph B Orange³⁰, David S Park^{31

32}, Stephen H Pasternak^{9

33}, Frederico Pieruccini-Faria^{2

14

29}, Tarek K Rajji^{23

24}, Angela C Roberts^{30

34}, John F Robinson^{2

6}, Ekaterina Rogaeva³⁵, Demetrios J Sahlas³⁶, Gustavo Saposnik^{8

15}, Christopher J M Scott⁵, Dallas Seitz³⁷, Christen Shoesmith²², Thomas D L Steeves³⁸, Michael J Strong^{2

39}, Stephen C Strother^{1

40}, Richard H Swartz^{5

8}, Sean Symons^{5

41}, David F Tang-Wai^{8

42}, Maria Carmela Tartaglia^{35

42}, Angela K Troyer^{26

43}, John Turnbull³⁶, Lorne Zinman^{5

8}, Paula M McLaughlin^{3

44}, Mario Masellis^{5

8}, Malcolm A Binns^{1

27}; ONDRI Investigators

Collaborators, Affiliations

Affiliations

¹ Rotman Research Institute, Baycrest Health Sciences, Toronto, Ontario, Canada.
² Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
³ Centre for Neuroscience Studies, Queen's University, Kingston, Ontario, Canada.
⁴ Thunder Bay Regional Health Research Institute, Thunder Bay, Ontario, Canada.
⁵ Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
⁶ Robarts Research Institute, Western University, London, Ontario, Canada.
⁷ Department of Medical Biophysics, Western University, London, Ontario, Canada.
⁸ Department of Medicine (Neurology), University of Toronto, Toronto, Ontario, Canada.
⁹ St. Joseph's Healthcare Centre, London, Ontario, Canada.
¹⁰ Toronto Western Hospital, Toronto, Ontario, Canada.
¹¹ Department of Kinesiology, University of Waterloo, Waterloo, Ontario, Canada.
¹² Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
¹³ Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
¹⁴ Lawson Health Research Institute, London, Ontario, Canada.
¹⁵ Keenan Research Centre for Biomedical Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
¹⁶ Bruyère Research Institute, Ottawa, Ontario, Canada.
¹⁷ Division of Neurology, Baycrest Health Sciences, Toronto, Ontario, Canada.
¹⁸ Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
¹⁹ Kensington Eye Institute, Toronto, Ontario, Canada.
²⁰ Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada.
²¹ School of Optometry and Vision Science, University of Waterloo, Waterloo, Ontario, Canada.
²² London Health Sciences Centre, London, Ontario, Canada.
²³ Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
²⁴ Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
²⁵ Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital, Toronto, Ontario, Canada.
²⁶ Department of Psychology, University of Toronto, Toronto, Ontario, Canada.
²⁷ Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
²⁸ Department of Clinical Neurological Sciences, London Health Sciences Centre, London, Ontario, Canada.
²⁹ Gait and Brain Lab, Parkwood Institute, London, Ontario, Canada.
³⁰ School of Communication Sciences and Disorders, Elborn College, Western University, London, Ontario, Canada.
³¹ Hotchkiss Brain Institute, Calgary, Alberta, Canada.
³² Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
³³ Cognitive Neurology and Alzheimer's Disease Research Centre, Parkwood Institute, London, Ontario, Canada.
³⁴ Roxelyn and Richard Pepper Department of Communication Sciences and Disorders, Northwestern University, Evanston, Illinois, USA.
³⁵ Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
³⁶ Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
³⁷ Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
³⁸ Division of Neurology, St. Michael's Hospital, Toronto, Ontario, Canada.
³⁹ Canadian Institutes for Health Research, Ottawa, Ontario, Canada.
⁴⁰ Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
⁴¹ Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.
⁴² Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada.
⁴³ Neuropsychology and Cognitive Health, Baycrest Health Sciences, Toronto, Ontario, Canada.
⁴⁴ Nova Scotia Health, Halifax, Nova Scotia, Canada.

PMID: 36318754
DOI: 10.1002/alz.12632

Observational Study

Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohort

Kelly M Sunderland et al. Alzheimers Dement. 2023 Jan.

. 2023 Jan;19(1):226-243.

doi: 10.1002/alz.12632. Epub 2022 Mar 30.

Authors

Affiliations

¹ Rotman Research Institute, Baycrest Health Sciences, Toronto, Ontario, Canada.
² Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
³ Centre for Neuroscience Studies, Queen's University, Kingston, Ontario, Canada.
⁴ Thunder Bay Regional Health Research Institute, Thunder Bay, Ontario, Canada.
⁵ Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
⁶ Robarts Research Institute, Western University, London, Ontario, Canada.
⁷ Department of Medical Biophysics, Western University, London, Ontario, Canada.
⁸ Department of Medicine (Neurology), University of Toronto, Toronto, Ontario, Canada.
⁹ St. Joseph's Healthcare Centre, London, Ontario, Canada.
¹⁰ Toronto Western Hospital, Toronto, Ontario, Canada.
¹¹ Department of Kinesiology, University of Waterloo, Waterloo, Ontario, Canada.
¹² Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
¹³ Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
¹⁴ Lawson Health Research Institute, London, Ontario, Canada.
¹⁵ Keenan Research Centre for Biomedical Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
¹⁶ Bruyère Research Institute, Ottawa, Ontario, Canada.
¹⁷ Division of Neurology, Baycrest Health Sciences, Toronto, Ontario, Canada.
¹⁸ Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
¹⁹ Kensington Eye Institute, Toronto, Ontario, Canada.
²⁰ Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada.
²¹ School of Optometry and Vision Science, University of Waterloo, Waterloo, Ontario, Canada.
²² London Health Sciences Centre, London, Ontario, Canada.
²³ Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
²⁴ Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
²⁵ Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital, Toronto, Ontario, Canada.
²⁶ Department of Psychology, University of Toronto, Toronto, Ontario, Canada.
²⁷ Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
²⁸ Department of Clinical Neurological Sciences, London Health Sciences Centre, London, Ontario, Canada.
²⁹ Gait and Brain Lab, Parkwood Institute, London, Ontario, Canada.
³⁰ School of Communication Sciences and Disorders, Elborn College, Western University, London, Ontario, Canada.
³¹ Hotchkiss Brain Institute, Calgary, Alberta, Canada.
³² Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
³³ Cognitive Neurology and Alzheimer's Disease Research Centre, Parkwood Institute, London, Ontario, Canada.
³⁴ Roxelyn and Richard Pepper Department of Communication Sciences and Disorders, Northwestern University, Evanston, Illinois, USA.
³⁵ Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
³⁶ Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
³⁷ Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
³⁸ Division of Neurology, St. Michael's Hospital, Toronto, Ontario, Canada.
³⁹ Canadian Institutes for Health Research, Ottawa, Ontario, Canada.
⁴⁰ Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
⁴¹ Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.
⁴² Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada.
⁴³ Neuropsychology and Cognitive Health, Baycrest Health Sciences, Toronto, Ontario, Canada.
⁴⁴ Nova Scotia Health, Halifax, Nova Scotia, Canada.

PMID: 36318754
DOI: 10.1002/alz.12632

Abstract

Introduction: Understanding synergies between neurodegenerative and cerebrovascular pathologies that modify dementia presentation represents an important knowledge gap.

Methods: This multi-site, longitudinal, observational cohort study recruited participants across prevalent neurodegenerative diseases and cerebrovascular disease and assessed participants comprehensively across modalities. We describe univariate and multivariate baseline features of the cohort and summarize recruitment, data collection, and curation processes.

Results: We enrolled 520 participants across five neurodegenerative and cerebrovascular diseases. Median age was 69 years, median Montreal Cognitive Assessment score was 25, median independence in activities of daily living was 100% for basic and 93% for instrumental activities. Spousal study partners predominated; participants were often male, White, and more educated. Milder disease stages predominated, yet cohorts reflect clinical presentation.

Discussion: Data will be shared with the global scientific community. Within-disease and disease-agnostic approaches are expected to identify markers of severity, progression, and therapy targets. Sampling characteristics also provide guidance for future study design.

Keywords: Alzheimer's disease; Parkinson's disease; amnestic mild cognitive impairment; amyotrophic lateral sclerosis; cerebrovascular disease; cohort study; dementia; frontotemporal dementia spectrum disorder; neurodegenerative disease.

PubMed Disclaimer

References

REFERENCES

1. Prince M, Wimo A, Guerchet M, Ali G, Wu Y, Prina M. Alzheimer's Disease International. World Alzheimer's report 2015: The Global Impact of Dementia. 2015.
1. Petersen RC, Aisen PS, Beckett LA, et al. Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 2010;74:201-209.
1. Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, et al. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int Psychogeriatr. 2009;21(4):672-687.
1. Rohrer JD, Nicholas JM, Cash DM, et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol. 2015;14:253-262.
1. Marek K, Chowdhury S, Siderowf A, et al. The Parkinson's progression markers initiative (PPMI)-establishing a PD biomarker cohort. Ann Clin Transl Neurol. 2018;5:1460-1477.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohort

Collaborators

Affiliations

Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohort

Authors

Collaborators

Affiliations

Abstract

References

REFERENCES

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical